Biotech entity

U.S. Medicaid

program

All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Angela Vasquez-Giroux, the most common co-covered peer. U.S. Medicaid appears in 1 tracked Biotech story from July 12, 2026. The tracked stories average 3 original sources each.

Last mentioned: Jul 12, 2026

Entity pulse

Recent coverage · U.S. Medicaid

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about U.S. Medicaid

All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Angela Vasquez-Giroux, the most common co-covered peer. U.S. Medicaid appears in 1 tracked Biotech story from July 12, 2026. The tracked stories average 3 original sources each.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering U.S. Medicaid. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Medicaid billing restored

    Planned Parenthood and two regional providers resume billing Medicaid for non-abortion services after nearly a year.

  2. Medicaid defunding enacted

    Trump administration tax and policy law mandates that abortion providers be excluded from all Medicaid reimbursement.

  3. Roe v. Wade overturned

    Supreme Court's Dobbs decision ends federal abortion rights, enabling state bans and increasing financial pressure on providers.

Stories mentioning U.S. Medicaid 1

Pharma Neutral

Birth Control Pill Prescriptions Fell 25% During Planned Parenthood Defunding, Hitting Pharma Markets

The year-long exclusion of Planned Parenthood from Medicaid led to a 25% decline in contraceptive prescriptions dispensed, affecting pharmaceutical sales volumes and signaling risk for manufacturers reliant on safety-net distribution channels. The funding restoration only partially alleviates the immediate demand shortfall, as clinic closures permanently remove points of dispensing.

3 sources

Source: kbzk.com · wxyz.com

U.S. Medicaid is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.